Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Cancer Genetics and Cytogenetics|January 29, 2003
Derivative (7)t(7;8)(q34;q21). a new additional cytogenetic abnormality in acute promyelocytic leukemiaJean Philippe Vial, François Xavier Mahon, Arnaud Pigneux, et al.
Hemasphere|November 15, 2019
Dasatinib-Loaded Erythrocytes Trigger Apoptosis in Untreated Chronic Myelogenous Leukemic Cells: A Cellular Reservoir Participating in Dasatinib EfficiencyKelly Airiau, Béatrice Turcq, Stéphane Bouchet, et al.
Cancers|February 10, 2021
Unsupervised Flow Cytometry Analysis Allows for an Accurate Identification of Minimal Residual Disease Assessment in Acute Myeloid LeukemiaJean Philippe Vial, Nicolas Lechevalier, Francis Lacombe, et al.
Annales De Biologie Clinique|October 21, 2023
Principal component analysis yields results comparable to those of an elaborate Boolean strategy: simplifying the assessment of measurable residual disease in chronic lymphocytic leukemia patientsVictor-Emmanuel Brett, Marie-Sarah Dilhuydy, Nicolas Lechevalier, et al.
Annales De Biologie Clinique|June 24, 2021
[Use of the multiparametric panel CD3/CD4/CD8/CD7/CD26/CD158k in the detection and use of flow cytometry of Sezary cells]Jonas Callet, Véronique Latger-Cannard, Delphine Gérard, et al.
Acta Dermato-Venereologica|June 27, 2022
A High Programmed Cell Death Protein 1 Hormone Receptor Score on Skin Biopsy is Associated with Sézary Syndrome Diagnosis: A Study of 91 Patients with ErythrodermaCamille Luherne, Sarah Menguy, Thomas Ferte, et al.
Ejhaem|February 26, 2024
Prognostic value of postinduction medullary myeloid recovery by flow cytometry in acute myeloid leukemiaCéline Row, Nicolas Lechevalier, Jean Philippe Vial, et al.
Plos One|March 17, 2017
TP53 alterations in primary and secondary Sézary syndrome: A diagnostic tool for the assessment of malignancy in patients with erythrodermaAudrey Gros, Elodie Laharanne, Marie Vergier, et al.
Blood Advances|September 27, 2021
CD158k and PD-1 expressions define heterogeneous subtypes of Sezary syndromeInès Vergnolle, Claudia Douat-Beyries, Serge Boulinguez, et al.
Cancer Medicine|February 24, 2024
Dismal outcome of refractory or relapsing patients with myelodysplasia-related acute myeloid leukemia partially alleviated by intensive chemotherapyHarmony Leroy, Noémie Gadaud, Emilie Bérard, et al.
Pageof 3